---
title: "Semble's £30M Series C: Modern Software for Healthcare Providers"
description: "UK healthcare-tech company Semble raised a £30M Series C led by Revaia in June 2026, scaling its practice-management platform for clinicians."
date: 2026-06-03T00:00:00.000Z
tags: ["2026-vc-news", "startup-funding", "venture-capital", "healthtech", "europe-vc"]
source: https://venturecapitaltracker.com/2026-semble-30m-series-c-health-tech
---

# Semble's £30M Series C: Modern Software for Healthcare Providers

> UK healthcare-tech company Semble raised a £30M Series C led by Revaia in June 2026, scaling its practice-management platform for clinicians.

Semble's **£30M Series C**, led by Revaia in June 2026, backs a steady European healthtech thesis: **modern, cloud-native software for clinicians** replacing aging practice systems.

### The problem this startup is attacking
Many healthcare providers still run on outdated, fragmented software. Semble offers a unified, modern platform for records, scheduling, and patient management.

### Why this is a live problem now
- Providers want efficiency amid staffing and cost pressures.
- Cloud-native, AI-ready platforms beat legacy systems.
- European health systems are modernizing IT.

### Competitive map
- Legacy practice-management and EHR vendors.
- Other European digital-health platforms.
- Regional health-system software incumbents.

### Market signal (the number to remember)
- **£30M Series C with Partech and Octopus Ventures** — durable investor support for clinician-facing software modernization.

### Practical takeaway (operator + investor)
Semble shows **provider software modernization** remains a reliable European category. Founders should emphasize clinician time-savings and interoperability; investors should value recurring revenue and switching costs.

### Sources
1. Startuprise (Semble £30M Series C): https://startuprise.co.uk/top-funding-wrap-of-the-week-01-june-05-june-2026/